Cardinal health reports second quarter fiscal year 2023 results and raises fiscal year 2023 non-gaap eps guidance

Revenue increased 13% to $51.5 billion gaap1 operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the medical segment; gaap diluted loss per share was $0.50 non-gaap operating earnings of $467 million were in-line with the second quarter of last year; non-gaap diluted eps increased 4% to $1.32 fiscal year 2023 non-gaap eps guidance raised to $5.20 to $5.50, from $5.05 to $5.40 dublin, ohio , feb. 2, 2023 /prnewswire/ -- cardinal health (nyse: cah) today reported second quarter fiscal year 2023 revenues of $51.5 billion, an increase of 13% from the second quarter of fiscal year 2022. second quarter gaap operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the medical segment.
CAH Ratings Summary
CAH Quant Ranking